Cargando…

Challenges of Empirical Antibiotic Therapy for Community-Acquired Pneumonia in Children

BACKGROUND: Community-acquired pneumonia (CAP) is a leading cause of morbidity and mortality globally, responsible for more than 14% of deaths in children younger than 5 years of age. Due to difficulties with pathogen identification and diagnostics of CAP in children, targeted antimicrobial therapy...

Descripción completa

Detalles Bibliográficos
Autor principal:	Rodrigues, Charlene M.C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522971/ https://www.ncbi.nlm.nih.gov/pubmed/28761583 http://dx.doi.org/10.1016/j.curtheres.2017.01.002

Ejemplares similares

Community-Acquired Pneumonia in Children: the Challenges of Microbiological Diagnosis
por: Rodrigues, C. M. C., et al.
Publicado: (2018)

Empiric Antibiotic Therapy in the Treatment of Community-acquired Pneumonia in a General Hospital in Saudi Arabia
por: Al-Tawfiq, Jaffar A., et al.
Publicado: (2019)

Empiric antibiotic selection for community-acquired pneumonia in US hospitals, 2013–2020
por: Wolford, Hannah, et al.
Publicado: (2023)

Combination antibiotic therapy for community-acquired pneumonia
por: Caballero, Jesus, et al.
Publicado: (2011)

Clinical response to antibiotic therapy for community-acquired pneumonia
por: Juvén, Taina, et al.
Publicado: (2004)

Atypical Pathogens in Adult Community-Acquired Pneumonia and Implications for Empiric Antibiotic Treatment: A Narrative Review
por: Garin, Nicolas, et al.
Publicado: (2022)

Use of MRSA Nasal Swab to Guide Empiric Antibiotic Treatment of Hospital Acquired or Community Acquired Pneumonia in a Pediatric Population
por: Linfesty, Daniel, et al.
Publicado: (2017)

2724. Community-acquired Pneumonia in Immunocompromised Patients: Predictors and Outcomes Associated with Empiric Broad-spectrum Antibiotic Treatment
por: Saravolatz, Louis, et al.
Publicado: (2023)

Empirical Antibiotic Therapy for Ventilator-Associated Pneumonia
por: Swanson, Joseph M., et al.
Publicado: (2013)

Efficacy of Empiric Antibiotic Coverage in Community-Acquired Pneumonia Associated with Each Atypical Bacteria: A Meta-Analysis
por: Eljaaly, Khalid, et al.
Publicado: (2021)

Prescription of antibiotics in community-acquired pneumonia in children: are we following the recommendations?
por: da Fonseca Lima, Eduardo Jorge, et al.
Publicado: (2016)

Immunomodulatory activity of pidotimod administered with standard antibiotic therapy in children hospitalized for community-acquired pneumonia
por: Esposito, Susanna, et al.
Publicado: (2015)

O01 Auditing the duration of antibiotic therapy for children treated as inpatients for community acquired pneumonia
por: Alexander, Emma, et al.
Publicado: (2023)

Community-Acquired Pneumonia and Hospital-Acquired Pneumonia in Adult Patients with Idiopathic Inflammatory Myopathy: Outcome and Antibiotic Therapy
por: Liang, Junyu, et al.
Publicado: (2020)

Impact of an Emergency Medicine Pharmacist on Appropriate Empiric Antibiotic Prescribing for Community-Acquired Pneumonia and Intra-Abdominal Infections
por: Kulwicki, Benjamin, et al.
Publicado: (2017)

Risk Factors and outcomes associated with inappropriate empiric broad-spectrum antibiotic use in hospitalized patients with community-acquired pneumonia
por: Gandhi, Tejal, et al.
Publicado: (2023)

1646. Optimizing Antibiotic Durations of Therapy in Pediatric Community-acquired Pneumonia
por: Cook, Gregory, et al.
Publicado: (2023)

Community-acquired pneumonia in children()
por: Cardinale, Fabio, et al.
Publicado: (2013)

Community-acquired pneumonia in children
por: Davies, H Dele
Publicado: (2003)

Macrolides (alone or in combination) should be used as first-line empirical therapy of community-acquired pneumonia in children: myth or maxim?
por: Warris, Adilia
Publicado: (2021)

Antibiotic Use and Outcomes in Young Children Hospitalized With Uncomplicated Community-Acquired Pneumonia
por: Hofto, Meghan E, et al.
Publicado: (2022)

Incidence of Antibiotic Treatment Failure in Patients with Nursing Home-Acquired Pneumonia and Community Acquired Pneumonia
por: Lopes, Mariana, et al.
Publicado: (2021)

Guideline for Antibiotic Use in Adults with Community-acquired Pneumonia
por: Lee, Mi Suk, et al.
Publicado: (2018)

Antibiotic use for community-acquired pneumonia in neonates and children: WHO evidence review
por: Mathur, Shrey, et al.
Publicado: (2018)

Etiology and the challenge of diagnostic testing of community-acquired pneumonia in children and adolescents
por: Rueda, Zulma Vanessa, et al.
Publicado: (2022)

Community acquired pneumonia among adult patients at an Egyptian university hospital: bacterial etiology, susceptibility profile and evaluation of the response to initial empiric antibiotic therapy
por: El-Sokkary, Rehab H, et al.
Publicado: (2018)

Antimicrobial therapy of community-acquired pneumonia
por: File, Thomas M., et al.
Publicado: (2004)

519. Longer Length of Antibiotic Therapy for Community-Acquired Pneumonia and Risk of Clostridium difficile Infection
por: Yi, Sarah H, et al.
Publicado: (2018)

Community-acquired pneumonia: challenges of the situation in Brazil
por: Gomes, Mauro
Publicado: (2018)

Adherence to Guidelines for Assessment and Empiric Antibiotics Recommendations for Community-Acquired Pneumonia at Ambo University Referral Hospital: Prospective Observational Study
por: Eticha, Endalkachew Mekonnen, et al.
Publicado: (2021)

A Case of Community-Acquired Tuberculosis in an Infant Presenting with Pneumonia Refractory to Antibiotic Therapy
por: Iness, Audra N, et al.
Publicado: (2023)

Management of community-acquired bacterial pneumonia in adults: Limitations of current antibiotics and future therapies
por: Nayar, Sandeep, et al.
Publicado: (2019)

Validation of an electronic algorithm to identify appropriate antibiotic use for community-acquired pneumonia in children
por: Chiotos, Kathleen, et al.
Publicado: (2023)

Quality of antibiotic prescribing for pediatric community-acquired Pneumonia in outpatient care
por: Saatchi, Ariana, et al.
Publicado: (2023)

Analysis of antibiotic usage for viral community-acquired pneumonia in adults
por: Jiang, Rongmeng, et al.
Publicado: (2020)

Empiric treatment of ambulatory community-acquired pneumonia: always include treatment for atypical agents
por: Marrie, Thomas J.
Publicado: (2004)

Antibiotics for paediatric community-acquired pneumonia in resource-constrained settings
por: Ginsburg, Amy Sarah, et al.
Publicado: (2020)

Empirical antibiotic treatment for community-acquired pneumonia and accuracy for Legionella pneumophila, Mycoplasma pneumoniae, and Clamydophila pneumoniae: a descriptive cross-sectional study of adult patients in the emergency department
por: Lorentzen, Morten Hjarnø, et al.
Publicado: (2023)

Viewing the Community-acquired Pneumonia Guidelines through an Antibiotic Stewardship Lens
por: Fabre, Valeria, et al.
Publicado: (2020)

Community-Acquired Pneumonia
por: Rider, Ashley C., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_49if4j57etlr6jft2l1l5s0tpk